Peter Mu‐Hsin Chang

1.3k citations
39 papers · 496 indexed · h-index 13
Topics
Head and Neck Cancer Studies (16 papers)Lung Cancer Treatments and Mutations (7 papers)Lung Cancer Research Studies (5 papers)

In The Last Decade

Peter Mu‐Hsin Chang

38 papers receiving 492 citations

Peers

Peter Mu‐Hsin Chang
Comparison fields: 5 of 67
  • Oncology 202
  • Molecular Biology 174
  • Otorhinolaryngology 128
  • Surgery 121
  • Pulmonary and Respiratory Medicine 88
Replace Joo Yong Park with:
Joo Yong Park South Korea
Neil Oronsky United States
Lei Cheng China
Simone Scagnoli Italy
Xiaohui Yuan China
Kaibo Guo China
Jaspreet Kaur India
Joanne Chiu China
Hui Han China
Kyohei Watanabe Japan
Peter Mu‐Hsin Chang relative to Joo Yong Park South Korea Joo Yong Park's profile →
Citations per field
00.5×1.5×
Joo Yong Park · 1×
Citations per year

Countries citing papers authored by Peter Mu‐Hsin Chang

Since Specialization
Citations

This map shows the geographic impact of Peter Mu‐Hsin Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Mu‐Hsin Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Mu‐Hsin Chang more than expected).

Fields of papers citing papers by Peter Mu‐Hsin Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Mu‐Hsin Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Mu‐Hsin Chang. The network helps show where Peter Mu‐Hsin Chang may publish in the future.

Co-authorship network of co-authors of Peter Mu‐Hsin Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Mu‐Hsin Chang. A scholar is included among the top collaborators of Peter Mu‐Hsin Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Mu‐Hsin Chang. Peter Mu‐Hsin Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 6
4 8
5 18
6 9
7 3
8 17
9 45
10 22
11 17
12 1
13 23
14 29
15 2
16 9
17 79
18 14
19 4
20 1

About Peter Mu‐Hsin Chang

Peter Mu‐Hsin Chang is a scholar working on Otorhinolaryngology, Oncology and Cancer Research, having authored 39 papers that have together received 496 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (16 papers), Lung Cancer Treatments and Mutations (7 papers) and Lung Cancer Research Studies (5 papers). The work is most often cited by research in Otorhinolaryngology (128 citations), Oncology (202 citations) and Cancer Research (76 citations). Peter Mu‐Hsin Chang has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include Pen‐Yuan Chu, Chi‐Ying F. Huang, Shyh‐Kuan Tai, Shyue‐Yih Chang, Muh‐Hwa Yang, Yi‐Fen Wang, Cheng‐Hwai Tzeng, Wing–Yin Li, Ming‐Huang Chen and Chun‐Yu Liu. Their work appears in journals such as PLoS ONE, Annals of Oncology and Annals of Surgical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026